Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 01:19PM ET
21.57
Dollar change
+0.55
Percentage change
2.62
%
IndexNDX, S&P 500 P/E32.44 EPS (ttm)0.66 Insider Own17.51% Shs Outstand863.67M Perf Week3.70%
Market Cap18.60B Forward P/E6.13 EPS next Y3.52 Insider Trans-0.00% Shs Float711.34M Perf Month1.94%
Income574.00M PEG- EPS next Q0.90 Inst Own59.65% Short Float4.38% Perf Quarter-19.03%
Sales142.41B P/S0.13 EPS this Y-18.47% Inst Trans-0.06% Short Ratio2.31 Perf Half Y2.62%
Book/sh22.60 P/B0.95 EPS next Y8.45% ROA0.60% Short Interest31.16M Perf Year-36.22%
Cash/sh0.91 P/C23.73 EPS next 5Y-5.02% ROE2.86% 52W Range19.68 - 36.58 Perf YTD-17.39%
Dividend Est.1.45 (6.72%) P/FCF- EPS past 5Y- ROI1.15% 52W High-41.03% Beta0.72
Dividend TTM1.69 (7.83%) Quick Ratio0.30 Sales past 5Y1.35% Gross Margin17.21% 52W Low9.58% ATR (14)0.64
Dividend Ex-DateFeb 16, 2024 Current Ratio0.66 EPS Y/Y TTM119.40% Oper. Margin1.29% RSI (14)54.34 Volatility2.21% 2.59%
Employees331000 Debt/Eq1.78 Sales Y/Y TTM7.73% Profit Margin0.40% Recom3.10 Target Price24.88
Option/ShortYes / Yes LT Debt/Eq1.57 EPS Q/Q98.20% Payout- Rel Volume2.59 Prev Close21.02
Sales Surprise3.32% EPS Surprise46.57% Sales Q/Q9.96% EarningsMar 28 BMO Avg Volume13.50M Price21.57
SMA203.04% SMA50-0.73% SMA200-11.06% Trades Volume21,226,955 Change2.62%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Initiated Leerink Partners Market Perform $23
Feb-20-24Downgrade HSBC Securities Hold → Reduce
Jan-03-24Initiated Barclays Underweight $21
Dec-22-23Initiated HSBC Securities Hold $27
Oct-23-23Upgrade JP Morgan Neutral → Overweight $27 → $30
Jul-03-23Reiterated Morgan Stanley Underweight $37 → $27
Jun-28-23Downgrade Deutsche Bank Buy → Hold $46 → $34
Feb-23-23Initiated Loop Capital Buy $45
Nov-23-22Resumed Morgan Stanley Underweight $39
Nov-22-22Upgrade Cowen Market Perform → Outperform $43 → $54
Today 12:50PM
12:18PM
11:53AM
11:34AM
11:32AM
11:24AM Loading…
11:24AM
11:08AM
11:07AM
11:06AM
10:54AM
10:47AM
10:38AM
10:06AM
09:43AM
09:32AM
09:30AM Loading…
09:30AM
08:38AM
08:31AM
08:21AM
08:15AM
08:10AM
08:02AM
07:20AM
07:20AM
07:10AM
07:07AM
07:07AM
07:00AM
Mar-27-24 05:05PM
04:30PM
11:18AM Loading…
Mar-26-24 11:18AM
10:35AM
06:05AM
Mar-25-24 12:09PM
11:26AM
09:15AM
Mar-24-24 02:00PM
10:58AM
07:56AM
Mar-23-24 05:43AM
Mar-22-24 05:45PM
04:31PM
07:37AM
Mar-21-24 05:50PM
12:37PM
10:00AM
08:30AM
06:16AM
Mar-20-24 01:23PM
08:15AM
Mar-18-24 06:00AM
05:55AM
01:00AM
Mar-15-24 05:45PM
10:05AM
Mar-14-24 01:41PM
09:26AM
09:00AM
Mar-13-24 01:15PM
08:37AM
06:00AM
Mar-12-24 05:50PM
03:31PM
12:15PM
09:26AM
08:30AM
Mar-11-24 07:03PM
05:51PM
05:39PM
12:14PM
Mar-10-24 07:10PM
06:44AM
Mar-09-24 12:14PM
Mar-08-24 12:30PM
11:30AM
03:13AM
Mar-07-24 12:28PM
12:25PM
Mar-06-24 05:45PM
Mar-04-24 11:37AM
11:10AM
10:00AM
09:51AM
09:42AM
09:30AM
08:26AM
03:58AM
Mar-01-24 04:27PM
01:28PM
01:09PM
11:40AM
11:36AM
11:27AM
11:12AM
03:48AM
Feb-29-24 10:05PM
07:41PM
05:45PM
11:15AM
09:19AM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walgreens Boots Alliance, Inc.10% OwnerFeb 07 '24Sale235.414,212,395991,639,90726,277,561Feb 09 07:00 AM
JARRETT VALERIE BDirectorJan 29 '24Buy22.444,45699,9934,456Jan 31 04:11 PM
SCHLICHTING NANCY MDirectorJan 16 '24Sale23.0515,209350,5670Jan 18 04:18 PM
WENTWORTH TIMOTHY CChief Executive OfficerJan 05 '24Buy24.2210,000242,220585,122Jan 08 07:29 AM
Gates Richard P.SVP, Chief Pharmacy OfficerNov 10 '23Sale20.451,00020,45073,929Nov 14 08:22 PM
Walgreens Boots Alliance, Inc.10% OwnerNov 09 '23Sale195.381,279,590249,999,89630,489,956Nov 14 07:15 AM
Walgreens Boots Alliance, Inc.10% OwnerAug 03 '23Sale189.271,320,858250,000,11531,769,546Aug 07 05:48 PM
DRISCOLL JOHN PATRICKEVP, Pres. U.S. HealthcareJun 30 '23Buy28.425,172146,98459,050Jul 05 06:57 PM
Walgreens Boots Alliance, Inc.10% OwnerJun 15 '23Sale181.17275,98450,000,02133,090,404Jun 20 06:03 AM
Walgreens Boots Alliance, Inc.10% OwnerMay 11 '23Sale170.77292,79250,000,09033,366,388May 15 05:18 PM
BREWER ROSALIND GCEOMar 29 '23Buy33.9510,000339,510369,945Mar 31 04:26 PM